Preclinical studies using genetic CaMKII inhibition or peptide inhibitors (like autocamtide inhibitory peptide (AIP) and CaMKII inhibitor peptide (CaMKIIN) have shown improved cardiac function and reduced arrhythmias in HF models [22]. Here, CAMK2G is linked to hydrops fetalis.